Morie Gertz, MD
Mayo Clinic
Rochester, MN, USA

An overview of Amyloidosis updates and abstracts at ASH 2016.

Dr. Gertz discusses the new drugs NEOD001and 11-1F4, and the use of daratumumab and carfilzomib in patients with cardiac amyloid.



Dr. Morie Gertz is a Hematologist/Oncologist and Chair of General Internal Medicine at the Mayo Clinic in Rochester, Minnesota. He treats both amyloidosis and multiple myeloma. Visit Dr. Morie Gertz’s full biography.

Previous Post
IMWG Conference Series: 58th Annual ASH Meeting San Diego, CA
Next Post
ASH 2016: Multiple Myeloma Overview - Dr. Morie Gertz

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.